Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
| Status: | Completed |
|---|---|
| Conditions: | Skin Cancer, Cancer, Skin and Soft Tissue Infections, HIV / AIDS |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | Any - 99 |
| Updated: | 4/6/2019 |
| Start Date: | January 29, 1992 |
| End Date: | August 23, 2016 |
Continuing Treatment for Children and Adults in the Center for Cancer Research
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and
follow-up for NCI patients not currently entered on an active research protocol. No
investigational treatments will be administered on this protocol....
follow-up for NCI patients not currently entered on an active research protocol. No
investigational treatments will be administered on this protocol....
Background:
It may be in the interest of the CCR to continue to follow and treat certain subjects after
they have completed their treatment and participation on a research protocol.
Objective:
To provide continuing treatment and medical follow-up for CCR subjects who have completed
their treatment and participation on a research protocol and who are not currently entered on
or eligible for another active research protocol.
Eligibility:
Subjects who have been previously enrolled on and received treatment according to an approved
CCR research protocol. (clinical trial)
It is in the best interest of the subject and the CCR for the subject to continue to receive
standard care and follow-up at the NIH.
Design:
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects
who have completed their treatment and participation on a research protocol and who are not
currently entered on an active research protocol.
No investigational treatments will be administered. This protocol is not be used as a
platform to perform pilot studies of off-label uses for standard agents.
It may be in the interest of the CCR to continue to follow and treat certain subjects after
they have completed their treatment and participation on a research protocol.
Objective:
To provide continuing treatment and medical follow-up for CCR subjects who have completed
their treatment and participation on a research protocol and who are not currently entered on
or eligible for another active research protocol.
Eligibility:
Subjects who have been previously enrolled on and received treatment according to an approved
CCR research protocol. (clinical trial)
It is in the best interest of the subject and the CCR for the subject to continue to receive
standard care and follow-up at the NIH.
Design:
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects
who have completed their treatment and participation on a research protocol and who are not
currently entered on an active research protocol.
No investigational treatments will be administered. This protocol is not be used as a
platform to perform pilot studies of off-label uses for standard agents.
- INCLUSION CRITERIA:
Subjects of any age who have been previously enrolled and treated on an approved CCR
research treatment protocol.
It is in the best interests of the subject and the CCR for the subject to continue to
receive treatment and follow-up at the NIH.
The subject or guardian signs the informed consent and agrees to the proposed treatment
regimen.
EXCLUSION CRITERIA:
Subjects who have not been previously treated on a CCR research treatment protocol.
Subjects who are receiving an investigational therapy.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials
